PREVIEW
... urprised expression on Tian Liangwei’s face, Xu Yun hesitated for a few seconds and decided to keep a low profile:
"That’s right, initially, I just planned to attempt a breakthrough in the fourth-generation Imidacloprid. But by coincidence, I suddenly thought of a situation where two males would still need a female for a second round of transmission, which might lead to a halved coverage rate.
Moreover, I wasn’t very satisfied with the insecticidal efficiency of the fourth genera ...
YOU MAY ALSO LIKE























